Scientists from the International Agency for Research (IARC) on Cancer participated in the European Cancer Screening and Early Detection Policy Summit. It held on 17 and 18 February 2026 in Brussels and online. The event brought together policymakers, cancer researchers, clinicians and patient organizations. They discussed strategies for expanding screening and early detection programmes across Europe.
The summit focused on translating scientific evidence into policy decisions that can strengthen population-based screening programmes. Discussions included the potential expansion of screening initiatives for cancers such as lung, prostate and gastric cancer, as well as the implementation of updated European recommendations on cancer screening.
During the event, IARC researchers presented scientific evidence related to screening effectiveness, programme implementation and quality assurance systems. A key theme was the importance of strong data infrastructure to monitor participation rates, evaluate outcomes and ensure the quality and equity of screening programmes. Participants also examined practical challenges associated with implementing new screening initiatives, including resource allocation, workforce capacity and public engagement.
The summit was organized by the European Cancer Organisation and supported by the European Health and Digital Executive Agency under the EU4Health programme. The discussions highlighted the importance of collaboration between research institutions, health authorities and civil society organizations in advancing effective screening policies.
By bringing together scientific expertise and policy leadership, the summit contributed to ongoing European efforts to improve early detection and reduce cancer mortality through evidence-based screening strategies.